| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 11.88 | 20.5% | 10.3% |
| Total Income | 11.88 | 20.5% | 10.3% |
| Expenditure | 12.01 | 9.6% | 20.3% |
| PBT | -0.10 | 91.2% | 94.3% |
| Net Profit | -0.14 | 87.5% | 92.2% |
| OPM | -1.07% | 10.12pp | 12.75pp |
| NPM | -1.21% | 10.13pp | 12.30pp |
| EPS | -0.05 | 88.1% | 28.6% |
NextPlat Reports Q2 2026 Revenue Growth and Reduced Net Loss
14 Aug 2026 · 14 Aug, 1:54 am
Summary
NextPlat Corp reported significantly improved operating results for the second quarter ended June 30, 2026, with consolidated revenue reaching approximately $11.9 million, a 21% sequential increase. The company achieved a record consolidated gross margin of approximately 40%, up from 22% in the prior-year period, driven by strong performance in its Healthcare Operations and e-Commerce segments. Net loss attributable to common stockholders decreased by approximately 92% to $0.1 million. Management highlighted a clear financial inflection point and a strategic shift towards higher-margin services, with a focus on converting pipeline into revenue and achieving sustainable profitability.
Key Highlights
- 1
Consolidated revenue for the second quarter ended June 30, 2026, was approximately $11.9 million, a sequential increase of approximately 21% over first quarter 2026 revenue.
- 2
Contracted pharmacy revenue increased 136% to approximately $2.2 million compared to the prior-year period, driven by growth in 340B contract revenue and new medication fulfillment services.
- 3
Second quarter 2026 e-Commerce revenue increased approximately 27% sequentially to approximately $4.1 million, supported by strong global demand for satellite-based connectivity and IoT products.
- 4
Overall gross margin for the second quarter reached a record level of approximately 40%, up approximately 18 percentage points from 22% in the prior-year second quarter.
- 5
Gross margin in the Healthcare Operations segment increased to approximately 46% in the second quarter of 2026, more than double the gross margin reported in the prior-year period.
- 6
Net loss attributable to common stockholders for the quarter ended June 30, 2026, decreased approximately 92% to approximately $0.1 million or ($0.05) per diluted share, compared to a net loss of approximately $1.8 million for the prior-year period.
- 7
The Company ended the quarter with approximately $11.9 million in cash and working capital of approximately $14.2 million.
Management Comments
David Phipps
The second quarter of 2026 marked a clear financial inflection point in NextPlat’s turnaround as we generated strong sequential revenue growth, expanded consolidated gross margin to a record 40%, and reduced our net loss to $144,000. NextPlat’s significantly improved financial results reflect a more efficient operating structure and a deliberate shift toward higher-margin 340B contracted pharmacy services. Supported by 11 new contracted entities signed during the first half of 2026 and customer onboarding underway, our focus is now on converting this pipeline into revenue, maintaining margin discipline, and achieving sustainable profitability including selective, strategically aligned acquisitions that can add scale and diversification.
Informational and educational content only. Not investment advice.